Analystreport

Mesoblast Limited (NASDAQ: MESO) was upgraded by analysts at StockNews.com to a "sell" rating.

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com